pharma · Non-Hodgkin Lymphoma · Advanced Solid Tumors · ADCT
ADC Therapeutics
ADC Therapeutics SA
ADC Therapeutics clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Lausanne, Vaud, Switzerland, CH
- Founded
- 2011
- Employees
- 272
- Programs
- 30
- Drugs
- 15
- Patents
- 22
ADC Therapeutics projects
14 ClinicalTrials.gov programs sponsored by ADC Therapeutics.
ADC Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ADCT-301
ADC Therapeutics SA
Acute Myeloid Leukemia (AML)
1 trial -
ADCT-602
ADC Therapeutics SA
Blasts 5 Percent or More of Bone Marrow Nucleated Cells
1 trial -
Camidanlumab Tesirine
ADC Therapeutics SA
Relapsed Hodgkin Lymphoma
1 trial -
Cyclophosphamide
ADC Therapeutics SA
Double-Expressor Lymphoma
1 trial -
Epcoritamab
ADC Therapeutics SA
Large B-cell Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Waldenstrom Macroglobulinemia
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Diffuse Large B-cell Lymphoma
4 trials -
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed Follicular Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed or Refractory Large B-cell Lymphoma
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Follicular Lymphoma
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Post-transplant Lymphoproliferative Disorder
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Diffuse Large B-Cell Lymphoma Refractory
1 trial -
Loncastuximab tesirine 150 µg/Kg
ADC Therapeutics SA
Marginal Zone Lymphoma
1 trial -
imvotamab
ADC Therapeutics SA
Non-Hodgkin Lymphoma
1 trial
Frequently asked questions
How many clinical projects does ADC Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.